ID   MK01_HUMAN              Reviewed;         360 AA.
AC   P28482;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   05-OCT-2010, entry version 129.
DE   RecName: Full=Mitogen-activated protein kinase 1;
DE            Short=MAP kinase 1;
DE            Short=MAPK 1;
DE            EC=2.7.11.24;
DE   AltName: Full=ERT1;
DE   AltName: Full=Extracellular signal-regulated kinase 2;
DE            Short=ERK-2;
DE   AltName: Full=MAP kinase isoform p42;
DE            Short=p42-MAPK;
DE   AltName: Full=Mitogen-activated protein kinase 2;
DE            Short=MAP kinase 2;
DE            Short=MAPK 2;
GN   Name=MAPK1; Synonyms=ERK2, PRKM1, PRKM2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92171961; PubMed=1540184; DOI=10.1016/0006-291X(92)91891-S;
RA   Owaki H., Makar R., Boulton T.G., Cobb M.H., Geppert T.D.;
RT   "Extracellular signal-regulated kinases in T cells: characterization
RT   of human ERK1 and ERK2 cDNAs.";
RL   Biochem. Biophys. Res. Commun. 182:1416-1422(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92316223; PubMed=1319925; DOI=10.1016/0014-5793(92)80612-K;
RA   Gonzalez F.A., Raden D.L., Rigby M.R., Davis R.J.;
RT   "Heterogeneous expression of four MAP kinase isoforms in human
RT   tissues.";
RL   FEBS Lett. 304:170-178(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-15, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   INTERACTION WITH HIV-1 NEF.
RX   MEDLINE=96386556; PubMed=8794306;
RA   Greenway A.L., Azad A., Mills J., McPhee D.A.;
RT   "Human immunodeficiency virus type 1 Nef binds directly to LCK and
RT   mitogen-activated protein kinase, inhibiting kinase activity.";
RL   J. Virol. 70:6701-6708(1996).
RN   [6]
RP   INTERACTION WITH NISCH.
RX   PubMed=11912194; DOI=10.1074/jbc.M111838200;
RA   Sano H., Liu S.C.H., Lane W.S., Piletz J.E., Lienhard G.E.;
RT   "Insulin receptor substrate 4 associates with the protein IRAS.";
RL   J. Biol. Chem. 277:19439-19447(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-187, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185 AND TYR-187, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [9]
RP   INTERACTION WITH ARHGEF2.
RX   PubMed=18211802; DOI=10.1016/j.bbrc.2008.01.066;
RA   Fujishiro S.H., Tanimura S., Mure S., Kashimoto Y., Watanabe K.,
RA   Kohno M.;
RT   "ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide
RT   exchange activity toward RhoA.";
RL   Biochem. Biophys. Res. Commun. 368:162-167(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-187, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-187, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-187, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=16094384; DOI=10.1038/nmeth776;
RA   Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,
RA   Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
RT   "Quantitative phosphoproteome analysis using a dendrimer conjugation
RT   chemistry and tandem mass spectrometry.";
RL   Nat. Methods 2:591-598(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185 AND TYR-187, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH HSF4.
RX   PubMed=16581800; DOI=10.1128/MCB.26.8.3282-3294.2006;
RA   Hu Y., Mivechi N.F.;
RT   "Association and regulation of heat shock transcription factor 4b with
RT   both extracellular signal-regulated kinase mitogen-activated protein
RT   kinase and dual-specificity tyrosine phosphatase DUSP26.";
RL   Mol. Cell. Biol. 26:3282-3294(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185 AND TYR-187, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [16]
RP   INTERACTION WITH ARRB2.
RX   PubMed=18435604; DOI=10.1042/BJ20080685;
RA   Xu T.-R., Baillie G.S., Bhari N., Houslay T.M., Pitt A.M., Adams D.R.,
RA   Kolch W., Houslay M.D., Milligan G.;
RT   "Mutations of beta-arrestin 2 that limit self-association also
RT   interfere with interactions with the beta2-adrenoceptor and the ERK1/2
RT   MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2
RT   MAPKs.";
RL   Biochem. J. 413:51-60(2008).
RN   [17]
RP   INTERACTION WITH ADAM15.
RX   PubMed=18296648; DOI=10.1158/1541-7786.MCR-07-2028;
RA   Zhong J.L., Poghosyan Z., Pennington C.J., Scott X., Handsley M.M.,
RA   Warn A., Gavrilovic J., Honert K., Kruger A., Span P.N., Sweep F.C.,
RA   Edwards D.R.;
RT   "Distinct functions of natural ADAM-15 cytoplasmic domain variants in
RT   human mammary carcinoma.";
RL   Mol. Cancer Res. 6:383-394(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185; TYR-187 AND
RP   SER-202, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185 AND TYR-187, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   FUNCTION AS A TRANSCRIPTIONAL REPRESSOR, AND DNA-BINDING.
RX   PubMed=19879846; DOI=10.1016/j.cell.2009.08.037;
RA   Hu S., Xie Z., Onishi A., Yu X., Jiang L., Lin J., Rho H.-S.,
RA   Woodard C., Wang H., Jeong J.-S., Long S., He X., Wade H.,
RA   Blackshaw S., Qian J., Zhu H.;
RT   "Profiling the human protein-DNA interactome reveals ERK2 as a
RT   transcriptional repressor of interferon signaling.";
RL   Cell 139:610-622(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-187, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-63; THR-181; THR-185;
RP   TYR-187; SER-202 AND SER-284, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-185 AND TYR-187, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Involved in both the initiation and regulation of
CC       meiosis, mitosis, and postmitotic functions in differentiated
CC       cells by phosphorylating a number of transcription factors such as
CC       ELK1. Phosphorylates EIF4EBP1; required for initiation of
CC       translation. Phosphorylates microtubule-associated protein 2
CC       (MAP2). Phosphorylates SPZ1 (By similarity). Phosphorylates heat
CC       shock factor protein 4 (HSF4) and ARHGEF2.
CC   -!- FUNCTION: Acts as a transcriptional repressor. Binds to a
CC       [GC]AAA[GC] consensus sequence. Repress the expression of
CC       interferon gamma-induced genes. Seems to bind to the promoter of
CC       CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and
CC       STAT1. Transcriptional activity is independent of kinase activity.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by phosphorylation on tyrosine and
CC       threonine in response to insulin and NGF. Both phosphorylations
CC       are required for activity (By similarity).
CC   -!- SUBUNIT: Interacts with MORG1 (By similarity). Binds to HIV-1 Nef
CC       through its SH3 domain. This interaction inhibits its tyrosine-
CC       kinase activity. Interacts with its substrates HSF4 and ARHGEF2.
CC       Interacts (phosphorylated form) with CAV2 ('Tyr-19'-phosphorylated
CC       form); the interaction, promoted by insulin, leads to nuclear
CC       location and MAPK1 activation (By similarity). Interacts with
CC       NISCH. Interacts with ARRB2. Interacts with ADAM15.
CC   -!- INTERACTION:
CC       P28562:DUSP1; NbExp=2; IntAct=EBI-959949, EBI-975493;
CC       P19419:ELK1; NbExp=1; IntAct=EBI-959949, EBI-726632;
CC       P02687:MBP (xeno); NbExp=1; IntAct=EBI-959949, EBI-908215;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-185 and Tyr-187, which activates
CC       the enzyme.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA77753.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Extracellular signal-regulated
CC       kinase entry;
CC       URL="http://en.wikipedia.org/wiki/Extracellular_signal-regulated_kinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84489; AAA58459.1; -; mRNA.
DR   EMBL; Z11694; CAA77752.1; -; mRNA.
DR   EMBL; Z11695; CAA77753.1; ALT_INIT; mRNA.
DR   EMBL; BC017832; AAH17832.1; -; mRNA.
DR   IPI; IPI00003479; -.
DR   PIR; JQ1400; JQ1400.
DR   RefSeq; NP_002736.3; -.
DR   RefSeq; NP_620407.1; -.
DR   UniGene; Hs.431850; -.
DR   PDB; 1PME; X-ray; 2.00 A; A=1-360.
DR   PDB; 1TVO; X-ray; 2.50 A; A=1-360.
DR   PDB; 1WZY; X-ray; 2.50 A; A=1-360.
DR   PDB; 2E14; X-ray; 3.00 A; A=1-360.
DR   PDB; 2OJG; X-ray; 2.00 A; A=2-359.
DR   PDB; 2OJI; X-ray; 2.60 A; A=2-359.
DR   PDB; 2OJJ; X-ray; 2.40 A; A=2-359.
DR   PDB; 3D42; X-ray; 2.46 A; B=184-191.
DR   PDB; 3D44; X-ray; 1.90 A; B=186-191.
DR   PDB; 3I5Z; X-ray; 2.20 A; A=1-360.
DR   PDB; 3I60; X-ray; 2.50 A; A=1-360.
DR   PDBsum; 1PME; -.
DR   PDBsum; 1TVO; -.
DR   PDBsum; 1WZY; -.
DR   PDBsum; 2E14; -.
DR   PDBsum; 2OJG; -.
DR   PDBsum; 2OJI; -.
DR   PDBsum; 2OJJ; -.
DR   PDBsum; 3D42; -.
DR   PDBsum; 3D44; -.
DR   PDBsum; 3I5Z; -.
DR   PDBsum; 3I60; -.
DR   ProteinModelPortal; P28482; -.
DR   DIP; DIP-519N; -.
DR   IntAct; P28482; 30.
DR   MINT; MINT-144006; -.
DR   STRING; P28482; -.
DR   PhosphoSite; P28482; -.
DR   OGP; P28482; -.
DR   PeptideAtlas; P28482; -.
DR   PRIDE; P28482; -.
DR   Ensembl; ENST00000215832; ENSP00000215832; ENSG00000100030.
DR   Ensembl; ENST00000398822; ENSP00000381803; ENSG00000100030.
DR   GeneID; 5594; -.
DR   KEGG; hsa:5594; -.
DR   UCSC; uc002zvn.1; human.
DR   CTD; 5594; -.
DR   GeneCards; GC22M022108; -.
DR   H-InvDB; HIX0016281; -.
DR   HGNC; HGNC:6871; MAPK1.
DR   HPA; CAB004229; -.
DR   HPA; HPA030069; -.
DR   MIM; 176948; gene.
DR   Orphanet; 567; Monosomy 22q11.
DR   PharmGKB; PA30616; -.
DR   eggNOG; prNOG10833; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P28482; -.
DR   OMA; QAFDVGP; -.
DR   OrthoDB; EOG9TTK32; -.
DR   PhylomeDB; P28482; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Pathway_Interaction_DB; arf6downstreampathway; Arf6 downstream pathway.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; bmppathway; BMP receptor signaling.
DR   Pathway_Interaction_DB; anthraxpathway; Cellular roles of Anthrax toxin.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   Pathway_Interaction_DB; pi3kcibpathway; Class IB PI3K non-lipid kinase events.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Pathway_Interaction_DB; ifngpathway; IFN-gamma pathway.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; trkrpathway; Neurotrophic factor-mediated Trk receptor signaling.
DR   Pathway_Interaction_DB; avb3_opn_pathway; Osteopontin-mediated events.
DR   Pathway_Interaction_DB; ps1pathway; Presenilin action in Notch and Wnt signaling.
DR   Pathway_Interaction_DB; tcrraspathway; Ras signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; smad2_3pathway; Regulation of cytoplasmic and nuclear SMAD2/3 signaling.
DR   Pathway_Interaction_DB; telomerasepathway; Regulation of Telomerase.
DR   Pathway_Interaction_DB; retinoic_acid_pathway; Retinoic acid receptors-mediated signaling.
DR   Pathway_Interaction_DB; s1p_s1p1_pathway; S1P1 pathway.
DR   Pathway_Interaction_DB; s1p_s1p2_pathway; S1P2 pathway.
DR   Pathway_Interaction_DB; s1p_s1p3_pathway; S1P3 pathway.
DR   Pathway_Interaction_DB; s1p_s1p4_pathway; S1P4 pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; prlsignalingeventspathway; Signaling events mediated by PRL.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; ret_pathway; Signaling events regulated by Ret tyrosine kinase.
DR   Pathway_Interaction_DB; syndecan_1_pathway; Syndecan-1-mediated signaling events.
DR   Pathway_Interaction_DB; syndecan_2_pathway; Syndecan-2-mediated signaling events.
DR   Pathway_Interaction_DB; trail_pathway; TRAIL signaling pathway.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Pathway_Interaction_DB; vegfr1_pathway; VEGFR1 specific signals.
DR   Pathway_Interaction_DB; lymphangiogenesis_pathway; VEGFR3 signaling in lymphatic endothelium.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_16888; Signaling by PDGF.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   Reactome; REACT_9417; Signaling by EGFR.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   NextBio; 21708; -.
DR   Bgee; P28482; -.
DR   CleanEx; HS_MAPK1; -.
DR   Genevestigator; P28482; -.
DR   GermOnline; ENSG00000100030; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0006917; P:induction of apoptosis; TAS:ProtInc.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0007268; P:synaptic transmission; TAS:ProtInc.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR008349; Erk_1_2_MAPK.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01770; ERK1ERK2MAPK.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell cycle; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Host-virus interaction;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Repressor;
KW   Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    360       Mitogen-activated protein kinase 1.
FT                                /FTId=PRO_0000186247.
FT   DOMAIN       25    313       Protein kinase.
FT   NP_BIND      31     39       ATP (By similarity).
FT   DNA_BIND    259    277
FT   MOTIF       185    187       TXY.
FT   COMPBIAS      2      9       Poly-Ala.
FT   ACT_SITE    149    149       Proton acceptor (By similarity).
FT   BINDING      54     54       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES      63     63       Phosphothreonine.
FT   MOD_RES     181    181       Phosphothreonine.
FT   MOD_RES     185    185       Phosphothreonine.
FT   MOD_RES     187    187       Phosphotyrosine.
FT   MOD_RES     190    190       Phosphothreonine (By similarity).
FT   MOD_RES     202    202       Phosphoserine.
FT   MOD_RES     284    284       Phosphoserine.
FT   CONFLICT     91     91       R -> Q (in Ref. 2; CAA77752).
FT   STRAND       25     30
FT   STRAND       39     44
FT   TURN         45     47
FT   STRAND       49     56
FT   HELIX        62     77
FT   STRAND       88     90
FT   TURN         95     97
FT   STRAND      101    106
FT   HELIX       112    118
FT   HELIX       123    142
FT   HELIX       152    154
FT   STRAND      155    157
FT   STRAND      163    165
FT   HELIX       176    178
FT   HELIX       191    193
FT   HELIX       196    198
FT   TURN        199    201
FT   HELIX       208    223
FT   HELIX       233    244
FT   HELIX       249    253
FT   HELIX       258    265
FT   HELIX       275    278
FT   HELIX       284    293
FT   TURN        298    300
FT   HELIX       304    308
FT   HELIX       311    313
FT   TURN        314    316
FT   HELIX       319    321
FT   HELIX       340    350
FT   HELIX       352    354
FT   TURN        356    358
SQ   SEQUENCE   360 AA;  41390 MW;  E85D0B2A5D2D724E CRC64;
     MAAAAAAGAG PEMVRGQVFD VGPRYTNLSY IGEGAYGMVC SAYDNVNKVR VAIKKISPFE
     HQTYCQRTLR EIKILLRFRH ENIIGINDII RAPTIEQMKD VYIVQDLMET DLYKLLKTQH
     LSNDHICYFL YQILRGLKYI HSANVLHRDL KPSNLLLNTT CDLKICDFGL ARVADPDHDH
     TGFLTEYVAT RWYRAPEIML NSKGYTKSID IWSVGCILAE MLSNRPIFPG KHYLDQLNHI
     LGILGSPSQE DLNCIINLKA RNYLLSLPHK NKVPWNRLFP NADSKALDLL DKMLTFNPHK
     RIEVEQALAH PYLEQYYDPS DEPIAEAPFK FDMELDDLPK EKLKELIFEE TARFQPGYRS
//
